title: Fecal microbiota transplantation and donor standardization.
abstract: Clostridium difficile diarrhea is a common and severe infectious disease. Antibiotics, which are standard initial treatment, are less effective for treating refractory or recurrent infection. Fecal microbiota transplantation, where healthy donor stool is transplanted into a patient, is an alternative to antibiotic therapy that requires standardization for donors and patients.
authors.affiliation: Division of Gastroenterology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: cowens@medicine.washington.edu.
authors.forename: Casey
authors.initials: C
authors.lastname: Owens
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Broussard
authors.forename: Christina
authors.initials: C
authors.lastname: Surawicz
mesh_terms: D001691:Biological Therapy / Q000592:standards*; D016360:Clostridioides difficile / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D003967:Diarrhea / Q000382:microbiology / Q000628:therapy*; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology / Q000628:therapy*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D064307:Microbiota
keywords: Clostridium difficile; diarrhea; fecal microbiota transplant